Brainsway wins Israeli nod for deep-brain stimulation device to treat depression | Regulatory Roundup

October 4, 2011 by MassDevice staff

Brainsway Ltd.'s (PINK:BRSYF) transcranial magnetic stimulation device won Israeli Ministry of Health approval to treat major depression, bipolar disorder and negative impairment in schizophrenia patients.

The approval clears Jerusalem-based Brainsway to sell the non-invasive TMS device, which delivers brief magnetic pulses to the brain, to four medical centers specializing in mental disorders.

Sign up to get our free newsletters delivered right to your inbox.

"We are very pleased to receive this vote of confidence in the Deep TMS technology from our homeland's regulatory authority. We are now working to update indications with the Israeli Ministry of Health to bring them more in line with the approvals that we've already received in Europe," CEO Uzi Sofer said in prepared remarks.

Permalink